---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-187641"
form_type: "8-K"
ticker: "JANX"
cik: "0001817713"
company_name: "Janux Therapeutics, Inc."
filed_at: "2026-04-28T23:59:59+00:00"
generated_at: "2026-05-15T03:05:44.978735+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Janux reclassifies director Eric Dobmeier from Class III to Class II to rebalance board classes

## Summary
- On April 28, 2026, Eric Dobmeier resigned as Class III director and immediately reappointed as Class II director.
- Change effective to achieve more equal balance among the three director classes on the Board.
- Dobmeier's service deemed uninterrupted for vesting, equity awards, and compensation purposes.
- Dobmeier continues on the Compensation Committee.

## SEC filing metadata
- accession: 0001193125-26-187641
- form_type: 8-K
- ticker: JANX
- cik: 0001817713
- company_name: Janux Therapeutics, Inc.
- filed_at: 2026-04-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817713/000119312526187641/0001193125-26-187641-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817713/000119312526187641/janx-20260428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-187641
- JSON: https://secwatch.observer/filing/0001193125-26-187641.json
- Plain text: https://secwatch.observer/filing/0001193125-26-187641.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.